Vimarsana
Biggest News Aggregation in the World

Group Ren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group Ren Today - Breaking & Trending Today

CSPAN U.S. Senate Sen. Mitch McConnell On Coronavirus Aid Package July 13, 2024 - Vimarsana News

CSPAN U.S. Senate Sen. Mitch McConnell On Coronavirus Aid Package July 13, 2024

Aid package endorsed by president trump. Here is what they had to say starting with Senate Majority leader mcconnell. Sen. Mcconnell as the global outbreak of the coronavirus continues to grow, its impact on American Families and Small Businesses is continuing to scale up. School closures are challenging childcared teachers, is competent in family life further. Main street Small Businesses and employees are grappling with an unprecedented situation where local leaders are effectively winding down their businesses of time through no fault of their own. Major industries are saying business dry u...

中药龙头强势涨停 板块望迎历史性发展机遇 - Vimarsana News

中药龙头强势涨停 板块望迎历史性发展机遇

2021-06-29 08:12:00 来源: 数据宝 举报 分享至 分享至好友和朋友圈 (原标题:中药龙头强势涨停!板块望迎历史性发展机遇,3股机构预测上涨空间超20%) 国家将完善发展环境,支持国家中医药服务出口基地å...

Source: 163.com
17只医药股年内股价翻番 医疗服务板块一马当先_中国经济网——国家经济门户 - Vimarsana News

17只医药股年内股价翻番 医疗服务板块一马当先_中国经济网——国家经济门户

  今年上半年,医药板块延续2020年高景气度。同花顺数据显示,截至6月28日收盘,申万医药生物行业指数年内上涨9.76%,位列申万28个一级行业第九位。个股方面,板块内逾半数个股年内股价上涨,其中17股涨幅超过100%,热景生物以362.48%(经前复权处理,下同)的涨幅居首,美迪西、哈三联涨幅超过200%。   粤开证券认为,医药生物板块上半年高景气度受到多重因素驱动,一方面,行业本身在医保支付和监管升级下面临新机遇,如医保谈判扩面及...

Source: ce.cn
中药板块有望迎来历史性发展机遇,3股机构预测上涨空间超20% _ 证券时报网 - Vimarsana News

中药板块有望迎来历史性发展机遇,3股机构预测上涨空间超20% _ 证券时报网

中药板块有望迎来历史性发展机遇,3股机构预测上涨空间超20% 数据宝 陈见南 2021-06-29 07:41 (原标题:中药龙头强势涨停!板块有望迎来历史性发展机遇,3股机构预测上涨空间超20%) 申万中药大涨3%,位居行业概念涨幅榜前列。个股方面,从市值角度看,市值最高的片仔癀昨日收盘上涨1.02%,市值排名第二的云南白药昨日收盘上涨3.88%,市值排名第三的同仁堂昨日收盘上涨10%。 公开信息显示,同仁堂是中药行业著名çš...

Source: stcn.com
中药龙头强势涨停!板块有望迎来历史性发展机遇 3股机构预测上涨空间超20% _ 东方财富网 - Vimarsana News

中药龙头强势涨停!板块有望迎来历史性发展机遇 3股机构预测上涨空间超20% _ 东方财富网

从一致上涨空间来看,云南白药、信邦制药、东阿阿胶这3股上涨空间超20%。   机构关注度最高的个股是云南白药,合计12家机构评级,昨日股价上涨近4%,一致上涨空间接近35%。海通国际预计公司2021-2023年收入分别为373.70/423.18/474.5亿元,分别同比增长14%/13%/12%;归母净利润分别为58.91/63.71/68.88亿元,分别同比增长7%/8%/8%,此外,海通国际给予公司对应目标价184.46元,维持“优于大市”评级。   资金面上,上述部分概念股近10日获杠杆资金或北向资é...